← Back to Search

Stem Cell Therapy

Stem Cell Therapy for Osteoarthritis

N/A

Recruiting

Led By Robert Vandermark, MD

Research Sponsored by InGeneron, Inc.

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Males and females ages: 18 - 75

Clinical symptoms consistent with wrist osteoarthritis

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 3, 6 and 12 months

Awards & highlights

Study Summary

This trial is testing a new way to treat wrist osteoarthritis by injecting ADRCs generated by the Transpose RT system. The trial will compare the safety and efficacy of this new treatment to a standard treatment.

Who is the study for?

Adults aged 18-75 with chronic wrist osteoarthritis confirmed by symptoms and radiographs, who can consent to participate. Excluded are pregnant or breastfeeding individuals, recent tobacco users, those with substance abuse history, certain infections (HIV, Hepatitis B/C), allergies to specific anesthetics or contrast agents, participants in other trials, chemotherapy patients, vulnerable populations unable to consent properly (e.g., mentally disabled), and those with inflammatory arthritis conditions or carpal tunnel syndrome.Check my eligibility

What is being tested?

The study is testing the safety and effectiveness of a single injection of adipose-derived stem cells (ADRCs) compared to corticosteroid injections for treating chronic wrist osteoarthritis. Participants will be randomly assigned to receive either ADRCs or corticosteroids without knowing which one they get.See study design

What are the potential side effects?

Possible side effects may include reactions at the injection site such as pain or swelling, allergic reactions to the injected materials or local anesthetics used during the procedure. There's also a risk of infection following any injection.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 18 and 75 years old.

Select...

I have symptoms like pain or stiffness in my wrist.

Select...

My wrist arthritis was confirmed by X-ray.

Select...

I can make my own medical decisions or have someone who can.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 3, 6 and 12 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~3, 6 and 12 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 3, 6 and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Safety - Incidence of Treatment-Emergent Adverse Events

Secondary outcome measures

Efficacy - Change in Function Scores on the PROMIS at All Follow-up Visits

Efficacy - Change in Function Scores on the QuickDASH at All Follow-up

Efficacy - Change in Pain Scores on the Visual Analog Scale (VAS)-pain Scale at All Follow-up Visits

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Adipose Derived Regenerative Cell groupExperimental Treatment1 Intervention

Subjects in the treated group will receive an Adipose derived regenerative cells (ADRCs) injection into the wrist using a fluoroscopic-guided injection .

Group II: Corticosteroid groupActive Control1 Intervention

Subjects in the active control group will receive a corticosteroid injection into the wrist using a fluoroscopic-guided injection.

0 / 4Eligibility criteria met

Find a Location

Who is running the clinical trial?

InGeneron, Inc.Lead Sponsor

8 Previous Clinical Trials

671 Total Patients Enrolled

1 Trials studying Osteoarthritis

40 Patients Enrolled for Osteoarthritis

Sanford HealthOTHER

48 Previous Clinical Trials

61,883 Total Patients Enrolled

2 Trials studying Osteoarthritis

290 Patients Enrolled for Osteoarthritis

Robert Vandermark, MDPrincipal InvestigatorSanford Health

Media Library

Adipose-derived stem cell injection (Stem Cell Therapy) Clinical Trial Eligibility Overview. Trial Name: NCT03503305 — N/A

Osteoarthritis Research Study Groups: Adipose Derived Regenerative Cell group, Corticosteroid group

Osteoarthritis Clinical Trial 2023: Adipose-derived stem cell injection Highlights & Side Effects. Trial Name: NCT03503305 — N/A

Adipose-derived stem cell injection (Stem Cell Therapy) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03503305 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there an opportunity to partake in this clinical research?

"In order to qualify for this medical trial, individuals must possess a diagnosis of arthrosis and be within the age range of 18-75. A total of 40 patients are required by researchers."

Answered by AI

Are there any open opportunities for participants in this clinical investigation?

"According to clinicaltrials.gov, the recruitment of participants for this medical trial is ongoing with the initial posting date being November 21st 2018 and last update being August 2nd 2022."

Answered by AI

How many people are participating in the experiment?

"Affirmative. According to information found on clinicaltrials.gov, this research endeavour is actively recruiting participants with the initial post date of November 21st 2018 and most recent update being August 2nd 2022. At present, they are seeking 40 subjects from two distinct locations."

Answered by AI